📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

Nvidia, TSMC, Five Below, Spirit Airlines and Eli Lilly fall premarket

Published 2024-07-17, 07:38 a/m
© Reuters
LLY
-
AMZN
-
NVDA
-
SAVE
-
FIVE
-
TSM
-

Investing.com -- U.S. stock futures fell sharply Wednesday, with the tech stocks in sharp retreat as the quarterly earnings season continues.

Here are some of the biggest premarket U.S. stock movers today:

  • Taiwan Semiconductor Manufacturing (NYSE:TSM) stock fell 5% after Donald Trump, the Republican candidate for the U.S. presidency, said Taiwan should pay the U.S. for supplying defense equipment, putting the spotlight on the island’s biggest company.

  • Nvidia (NASDAQ:NVDA) stock fell 4% and ASML (AS:ASML) ADRs dropped almost 8% following a Bloomberg report that said the Biden administration is considering clamping down on companies exporting their critical chipmaking equipment to China.

  • Amazon (NASDAQ:AMZN) stock fell 1.1%, weighed by the overall negative tone even though the online retail giant’s annual Prime Day two-day shopping event, which concludes later, could see its sales rise 10.5% from last year, according to forecasts from Adobe (NASDAQ:ADBE).

  • Five Below (NASDAQ:FIVE) stock slumped 15% after the discount retailer said that its CEO Joel Anderson had stepped down and preannounced second-quarter guidance that fell short of estimates.

  • Johnson & Johnson (NYSE:JNJ) stock fell 0.3% despite the healthcare giant reporting a robust second quarter, with both earnings and revenue surpassing Wall Street estimates, driven by strong sales of its drugs.

  • Spirit Airlines (NYSE:SAVE) stock dropped 6.3% after the carrier lowered its second-quarter revenue outlook, citing lower-than-expected non-ticket revenue.

  • JB Hunt (NASDAQ:JBHT) stock fell 2.9% after the transportation company reported a 24% drop in second-quarter profit as well as a 7% decrease in total operating revenue.

  • Eli Lilly (NYSE:LLY) and Novo Nordisk (CSE:NOVOb) (NYSE:NVO) both dropped 3.7% after Swiss rival Roche (SIX:RO) revealed promising early-stage trial data from its latest obesity drug candidate.
  • Synchrony Financial (NYSE:SYF) stock fell 0.2% despite the financial services company posting a nearly 12% rise in second quarter net profit, driven by higher income from loans that offset an increase in the consumer banking firm's loan loss reserves.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.